FDA Inspection 1166865 — Allergan Sales, LLC

Allergan Sales, LLC — FEI 1643525

The FDA completed an inspection of Allergan Sales, LLC on March 24, 2022 in Waco, TX. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Drugs.

Inspection Details

Classification
No Action Indicated (NAI) (NAI)
End Date
March 24, 2022
Fiscal Year
2022
Product Type
Drugs
Project Area
Drug Quality Assurance
Location
Waco, TX (United States)